These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1122261)

  • 21. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 22. 3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa.
    Prasad AL; Fahn S
    Biochem Med; 1974 Feb; 9(2):136-47. PubMed ID: 4822034
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.
    Gluck MR; Zeevalk GD
    J Neurochem; 2004 Nov; 91(4):788-95. PubMed ID: 15525332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The estimation of 3,4-dihydroxyphenylacetic acid, homovanillic acid and homo-isovanillic acid in nervous tissue by gas-liquid chromatography and electron capture detection.
    Pearson JD; Sharman DF
    Br J Pharmacol; 1975 Jan; 53(1):143-8. PubMed ID: 164966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by apomorphine of dopamine deamination in the rat brain.
    Di Chiara G; Balakleevsky A; Porceddu ML; Tagliamonte A; Gessa GL
    J Neurochem; 1974 Dec; 23(6):1105-8. PubMed ID: 4452897
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The catabolism of catecholamines. Recent studies.
    Sharman DF
    Br Med Bull; 1973 May; 29(2):110-5. PubMed ID: 4584703
    [No Abstract]   [Full Text] [Related]  

  • 28. The fate of C14-dihydroxyphenylalanine (C14-dopa) in the whole mouse.
    Wurtman RJ; Chou C; Rose C
    J Pharmacol Exp Ther; 1970 Sep; 174(3):351-6. PubMed ID: 5456168
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine.
    Edwards DJ; Sedlock ML
    J Pharm Pharmacol; 1982 Oct; 34(10):685-6. PubMed ID: 6128399
    [No Abstract]   [Full Text] [Related]  

  • 30. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography.
    Wiesel FA; Sedvall G
    Brain Res; 1974 Jan; 65(3):547-50. PubMed ID: 4415145
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on rheomelanins. I. The formation of rheomelanins in human blood plasma from catecholamines, from L-dopa and from some of their derivatives.
    Hegedus ZL; Altschule MD
    Arch Int Physiol Biochim; 1970 Aug; 78(3):443-59. PubMed ID: 4097994
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].
    Bird ED; Crow TJ; Iversen LL; Longden A; Mackay AV; Riley GJ; Spokes EG
    J Physiol; 1979 Aug; 293():36P-37P. PubMed ID: 501607
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic administration of alpha-methyldopa: regional levels of endogenous and alpha-methylated catecholamines in rat brain.
    Conway EL; Louis WJ; Jarrott B
    Eur J Pharmacol; 1978 Dec; 52(3-4):271-80. PubMed ID: 729639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long-term effects on the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.
    Peyrin L; Simon H; Cottet-Emard JM; Bruneau N; Le Moal M
    Brain Res; 1982 Mar; 235(2):363-9. PubMed ID: 6821353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900
    [No Abstract]   [Full Text] [Related]  

  • 37. Implications of catecholamine systems of the brain in schizophrenia.
    Matthysse S
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():305-15. PubMed ID: 4155111
    [No Abstract]   [Full Text] [Related]  

  • 38. Catecholamine and octopamine concentrations in brains of patients with Reye syndrome.
    Lloyd KG; Davidson L; Price K; McClung HJ; Gall DG
    Neurology; 1977 Oct; 27(10):985-8. PubMed ID: 333308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathectomy does not modify the levels of dopa or dopamine in the rat dorsal root ganglion.
    Bertrand A; Weil-Fugazza J
    Brain Res; 1995 May; 681(1-2):201-4. PubMed ID: 7552281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of haloperidol on the urinary excretion of dopamine, homovanillic and vanilmandelic acids in schizophrenics.
    Bruno A; Allegranza A
    Psychopharmacologia; 1965 Jun; 8(1):60-6. PubMed ID: 5851219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.